Marc Buyse is the founder of the International Drug Development Institute (IDDI) and of CluePoints Inc. He is Associate Professor of Biostatistics at Hasselt University in Belgium. He holds degrees in engineering and statistics from Brussels University (ULB), management from the Cranfield School of Management (Cranfield, UK) and a doctorate in biostatistics from Harvard University (Boston, MA). He was President of the International Society for Clinical Biostatistics, President of the Quetelet Society, and Fellow of the Society for Clinical Trials. He worked at the EORTC (European Organization for Research and Treatment of Cancer) in Brussels and at the Dana Farber Cancer Institute in Boston. He currently serves on the editorial board of the journals Cancer Investigation, Clinical Trials, Biometrical Journal, Journal of Clinical Oncology, Statistical Methods in Medical Research, and Statistics in Biopharmaceutical Research.